Skip to main content
Premium Trial:

Request an Annual Quote

Cellectricon, Fluxion Settle Microfluidic Cellular Analysis IP Dispute

NEW YORK (GenomeWeb News) – Cellectricon and Fluxion Biosciences announced today they have settled a legal dispute dating back to 2009 in which Fluxion was accused of patent infringement.

Under the terms of the settlement, the firms will cross-license patents related to microfluidic cellular analysis.

Cellectricon and Fluxion said they will ask the US District Court for the Northern District of California to dismiss all claims that Cellectricon brought against Fluxion involving US Patent Nos. 7,390,650; 7,470,518; and 7,563,614.

"Resolution of this lawsuit allows us to focus on providing innovative and enabling products and discovery services for drug discovery and life science research globally," Cellectricon CEO David Burns said in a statement.

Jeff Jensen, CEO of Fluxion, added, "We believe it is a win-win for both companies, and will benefit our customers as we can now focus all of our attention on developing and providing solutions that continue to deliver maximum benefit to them."

When Cellectricon sued Fluxion, it alleged infringement of four patents — the three covered by today's settlement announcement, as well as US Patent No. 5,376,252, a patent held by Gyros but licensed to Cellectricon. The firms settled the dispute over the '252 patent late last year.

The patents covered microfluidic technology used in Cellectricon's ion channel drug screening solution, the Dynaflow HT System. Cellectricon had claimed Fluxion's IonFlux automated patch clamp system infringed the patents, as GenomeWeb Daily News' sister publication BioArray News previously reported.

Cellectricon, based on MöIndal, Sweden provides cellular screening technologies. Fluxion, headquartered in South San Francisco, Calif., provides analytical instruments for functional cell-based assays.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.